Vineesh Chandran-Indira

Aarhus N, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Development and preclinical evaluation of an asialoglycoprotein receptor 1-targeted antibody-drug conjugate in hepatic inflammation.

Development and preclinical evaluation of an asialoglycoprotein receptor 1-targeted antibody-drug conjugate in hepatic inflammation.

Journal: International journal of biological macromolecules

Published: September 18, 2025

Extracellular vesicles as liquid biopsy tools for personalized therapeutic goals in glioblastoma.

Extracellular vesicles as liquid biopsy tools for personalized therapeutic goals in glioblastoma.

Journal: Brain : a journal of neurology

Published: June 21, 2025

Extracellular vesicles as liquid biopsy tools for personalized therapeutic goals in glioblastoma.

Extracellular vesicles as liquid biopsy tools for personalized therapeutic goals in glioblastoma.

Journal: Brain : a journal of neurology

Published: June 21, 2025

Ability of soluble TREM2 and PRO-C3 as biomarkers to predict changes in MASLD activity.

Ability of soluble TREM2 and PRO-C3 as biomarkers to predict changes in MASLD activity.

Journal: JHEP reports : innovation in hepatology

Published: January 05, 2025

Revisiting the Role of miRNAs in Neuropathology.

Revisiting the Role of miRNAs in Neuropathology.

Journal: Neurology India

Published: December 16, 2024

Micro RNA profiles of host extracellular vesicles are modulated by Ascaris suum infection but parasite extracellular vesicle miRNAs are systemically undetectable using in-depth miRNA sequencing.

Micro RNA profiles of host extracellular vesicles are modulated by Ascaris suum infection but parasite extracellular vesicle miRNAs are systemically undetectable using in-depth miRNA sequencing.

Journal: International journal for parasitology

Published: February 26, 2024

Extracellular vesicles in glioblastoma: a challenge and an opportunity.

Extracellular vesicles in glioblastoma: a challenge and an opportunity.

Journal: NPJ precision oncology

Published: December 08, 2023

Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163.

Obese Patients With Nonalcoholic Fatty Liver Disease Have an Increase in Soluble Plasma CD163 and a Concurrent Decrease in Hepatic Expression of CD163.

Journal: Gastro hep advances

Published: January 25, 2023

The prevalence and risk factors for cognitive impairment in obesity and NAFLD.

The prevalence and risk factors for cognitive impairment in obesity and NAFLD.

Journal: Hepatology communications

Published: January 25, 2023

Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity.

Stellate cell expression of SPARC-related modular calcium-binding protein 2 is associated with human non-alcoholic fatty liver disease severity.

Journal: JHEP reports : innovation in hepatology

Published: July 05, 2022

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer.

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer.

Journal: Translational oncology

Published: March 30, 2022

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness.

Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness.

Journal: Hepatology (Baltimore, Md.)

Published: January 18, 2022

Showing 1-12 of 22

Last Updated: 09/26/2026